Skin melanoma, malignant (ICD10 C43): combined sexes

Five-year relative survival by HSE area of residence and age at diagnosis (2003-2007 diagnosis period)

	Five-year relative survival (with 95% confidence interval) by HSE area of residence (2003-2007)
Age at diagnosis	Total	Dublin /	Dublin /	South	West
		Mid Leinster	North East
all 15-99	86.6%	88.5%	84.1%	89.4%	82.1%
(unstandardized)	(84.1-88.8%)	(84.4-91.9%)	(78.1-89.1%)	(84.5-93.5%)	(76.0-87.3%)
all 15-99	86.0%	86.9%	81.9%	87.9%	81.1%
(age-standardized)#	(80.5-90.5%)	(77.4-93.9%)	(68.5-91.5%)	(76.7-95.6%)	(68.2-90.4%)
15-44	91.4%	91.3%	89.3%	89.2%	96.4%
	(88.4-93.5%)	(86.4-94.6%)	(82.1-93.8%)	(81.1-93.9%)	(91.3-98.6%)
45-54	85.7%	88.2%	79.3%	87.6%	82.8%
	(80.1-89.9%)	(79.3-93.7%)	(62.5-89.5%)	(74.5-94.5%)	(69.1-91.1%)
55-64	85.2%	80.1%	90.2%	91.9%	73.7%
	(80.0-89.3%)	(69.6-87.8%)	(80.4-95.6%)	(84.8-96.4%)	(56.5-85.6%)
65-74	82.0%	90.9%	78.3%	82.2%	69.4%
	(75.4-87.6%)	(80.5-98.1%)	(63.6-88.9%)	(69.5-91.8%)	(53.0-82.5%)
75-99	82.4%	81.2%	63.1%	87.7%	76.6%
	(72.9-91.3%)	(65.3-95.4%)	(38.5-86.7%)	(69.2-100%)	(60.1-91.9%)

Footnotes:

# Age-standardized figures (presented for the more common cancers) use the standard patient population proposed for this cancer by:

Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316.

(Population weights = age 15-44 x28000, 45-54 x17000, 55-64 x21000, 65-74 x20000, 75-99 x14000)

Exclusions (as in EUROCARE):

Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; second or subsequent malignancies in the same patient

(or the less serious of two or more synchronously-diagnosed malignancies); in situ carcinomas and tumours of uncertain behaviour.

© National Cancer Registry Ireland 2011 (October 2011)  Relative survival statistics for Irish cancer patients